Stable Coacervate Microdroplets as Robust Microreactors for Enhanced Enzymatic Catalysis
Researchers have engineered highly stable coacervate microdroplets using polyethyleneimine (PEI) and sodium thioctate (ST) that resist coalescence for over 35 days without any additives. The droplets exploit electrostatic and hydrophobic interactions, creating a charge‑repelled surface that preserves structural integrity. They demonstrate exceptional molecular recruitment, accommodating small molecules, polymers, and proteins. When employed as enzymatic microreactors, they accelerate esterase‑catalyzed hydrolysis of 4‑nitrophenyl acetate up to 53‑fold, showcasing their potential for biomimetic catalysis.
Multifunctional Biomimetic Hematoma Microspheres for Sustained Local Hydrogen Sulfide (H2S) Delivery to Enhance Vascularized Bone Regeneration
Researchers have engineered biomimetic hematoma microspheres that combine a pH‑responsive GelMA outer layer with a NaHS‑loaded liposomal core to deliver hydrogen sulfide (H₂S) directly to bone defect sites. The microspheres release H₂S in acidic environments, simultaneously reducing chronic inflammation, stimulating...
Alginate/PCL Dressing for Silver Nanoparticle and PDGF-B Delivery
Researchers have engineered an alginate/polycaprolactone (PCL) composite dressing that co‑delivers silver nanoparticles and platelet‑derived growth factor‑B (PDGF‑B). The hybrid matrix provides sustained antimicrobial release while preserving the bioactivity of PDGF‑B to stimulate tissue regeneration. In vivo tests on rodent wound...
Johnson & Johnson’s Pipeline Strategy: What Does 2026 Have in Store for the Big Pharma?
Johnson & Johnson entered 2026 aiming for $100‑$101 billion in sales after a 9.1 % Q4 revenue rise to $24.6 billion. The company is banking on its oncology portfolio—particularly Darzalex, Tecvayli, Carvykti and emerging lung‑cancer combos—to offset the imminent loss of exclusivity for...
TrumpRx Delayed Amid Potential Anti-Kickback Concerns
The White House postponed the rollout of TrumpRx, the federal direct‑to‑consumer drug marketplace. Officials cite potential violations of the federal anti‑kickback statute as a key factor, prompting HHS to issue a guidance bulletin outlining required safeguards. Major manufacturers including Pfizer,...
EMA Looks Into 'Data Integrity' Issue with Amgen's Tavneos
The European Medicines Agency has opened a review into the data integrity of the pivotal ADVOCATE trial that underpinned the EU approval of Amgen’s oral complement C5 inhibitor Tavneos. The regulator’s concerns focus on how the study data were handled...
How Brick-Building Bacteria React to Toxic Chemical in Martian Soil
Researchers at the Indian Institute of Science examined how perchlorate, a toxic chemical in Martian regolith, influences biocementation by a robust native strain of Sporosarcina pasteurii. While perchlorate slows bacterial growth, it triggers extracellular matrix formation that creates microbridges, resulting...
Sorghum Genotypes Show Anthracnose Resistance in Ethiopia
Researchers in Ethiopia identified several sorghum genotypes that exhibit strong resistance to anthracnose, a fungal disease that can devastate yields. Field trials across major growing regions showed up to 20% higher grain production compared with susceptible varieties under disease pressure....
Pinus Nigra’s Defense Mechanisms Against Diplodia Sapinea
Researchers have detailed how Pinus nigra (black pine) resists infection by the fungal pathogen Diplodia sapinea, which causes tip blight and significant timber loss. The study highlights rapid resin exudation, elevated phenolic production, and a coordinated transcriptional shift toward defense...
Sanofi Moves Away From mRNA Flu Vaccine as CEO Projects Confidence
Sanofi announced it has deprioritized its SP0237 mRNA‑based seasonal flu vaccine, removing the candidate from near‑term launch plans. The hexavalent shot was in a Phase I/II safety and immunogenicity trial for adults over 50, which remains active but is not recruiting...
Mosaic’s Nanoneedle Granted Advanced Manufacturing Technology Designation for Gene Therapy Products
The FDA’s Center for Biologics Evaluation and Research granted NanoMosaic an Advanced Manufacturing Technology (AMT) designation for its Nanoneedle platform, which multiplexes vector genome and capsid titer testing in AAV gene‑therapy production. The designation confirms the technology’s ability to streamline...
IDDI Unveils New Brand, Marks 35 Years of Clinical Data Science Excellence
IDDI, a global clinical data science partner, launched a refreshed brand to mark its 35‑year anniversary, debuting publicly at the SCOPE Summit on February 2, 2026. The new identity underscores a patient‑centric approach, biostatistical rigor, and regulatory insight while highlighting...
Summit’s Potential Keytruda Rival Gets November FDA Decision Date
The U.S. Food and Drug Administration has set a November 14 deadline to rule on Summit Therapeutics’ bispecific antibody ivonescimab, which targets PD‑1 and VEGF in EGFR‑mutant non‑small cell lung cancer. Summit’s Phase III HARMONi trial demonstrated a roughly 50% improvement in...
Three More Biotechs Price Their Nasdaq IPOs
AgomAb Therapeutics, SpyGlass Pharma, and Veradermics have filed Nasdaq IPO pricing, each seeking $150‑200 million. AgomAb plans to sell 2.5 million shares at $15‑$17, targeting a post‑money valuation near $875 million. SpyGlass will issue 9.4 million shares at the same price range, aiming for...
Janux Hires CMO After T Cell Engager Deal with Bristol Myers; A Batch of Appointments at Lexeo
Janux Therapeutics announced the appointment of William Go, M.D., Ph.D., as its new chief medical officer, replacing Zachariah McIver. The hire follows a recently disclosed partnership with Bristol Myers Squibb that provides a $50 million upfront payment for Janux’s T‑cell engager...
Politicization Runs Deeper than Ever at FDA, Risking Long-Term Impacts
The FDA has undergone an unprecedented wave of politicization in the past year, marked by mass staff departures, early retirements, and a surge of political appointees across senior roles. This shift has altered advisory committees, review processes, and introduced the...
Reed Jobs' Cancer Biotech Investment Firm Yosemite Eyes $350M Fund
Yosemite, the cancer‑research investment firm led by Reed Jobs, is seeking to raise a fund of up to $350 million. The capital target positions the firm among the largest early‑stage biotech funds currently forming. Jobs leverages his Silicon Valley connections and...
AI Battle: GPT-5, DeepSeek, Claude Tackle Dental MCQs
A recent study evaluated three leading AI models—GPT‑5, DeepSeek, and Claude—on multiple‑choice questions that simulate dental treatment scenarios for medically compromised patients. GPT‑5 delivered the most accurate and comprehensive answers, while DeepSeek excelled in localized problem solving but faltered on...
Metformin Shown to Prevent Long COVID Across Risk Groups in Multiple Randomized Trials
Multiple randomized trials and electronic‑health‑record analyses show that a 14‑day course of metformin, started during or shortly after acute SARS‑CoV‑2 infection, significantly lowers the risk of developing Long COVID. Across four studies, one Long COVID case is prevented for every...
Building a Smart Oncology Pipeline with Cumulus Oncology
Dr. Clare Wareing, founder and CEO of Cumulus Oncology, discussed the company’s risk‑adjusted preclinical pipeline aimed at high‑unmet‑need cancers. Cumulus employs a platform‑agnostic, precision‑medicine strategy that prioritizes patient subgroups to improve development success. The interview highlighted the supportive Scottish biotech...
Timing of Cord Blood Transplant Affects Graft Disease
Researchers have linked the circadian rhythm of soluble CD26 (sCD26) to acute graft‑versus‑host disease (aGVHD) risk in cord blood transplantation (CBT). Peak sCD26 levels suppress pathogenic T‑cell activity, creating a temporal window that lowers aGVHD incidence and severity. The team...
Systemic Immune-Inflammation Index Predicts Pediatric AKI Risk
A recent Pediatric Research study demonstrates that the systemic immune‑inflammation index (SII) predicts mortality in critically ill children with acute kidney injury (AKI). The researchers analyzed ICU data, finding that higher SII scores—reflecting neutrophilia, lymphopenia, and thrombocytosis—correlate with increased death...
Elusive Biomarkers Challenge Necrotizing Enterocolitis Diagnosis
Dr. Josef Neu’s recent article argues that reliable biomarkers for necrotizing enterocolitis (NEC) remain elusive due to the disease’s heterogeneity, methodological flaws in prior studies, and the unique physiology of preterm infants. He highlights that single‑molecule indicators such as cytokines...
Combating Salmonella and Listeria in Apple Juice
The U.S. Food and Drug Administration released new guidance on mitigating Salmonella and Listeria contamination in commercially bottled apple juice. The recommendations emphasize high‑temperature short‑time (HTST) pasteurization, routine environmental testing, and the adoption of antimicrobial hurdle technologies. Early adopters report...
Why ‘Natural’ Isn’t Enough: The Science of Pregnancy-Safe Skincare
Pregnancy fundamentally changes skin physiology, increasing permeability and absorption of topical ingredients, which means that products deemed safe for the general population may pose risks to mother and baby. The article debunks the myth that “natural” automatically equals safe, highlighting...
Transforming Healthcare Training for Autistic Clients
A coalition of health systems and autism advocacy groups launched a $12 million training program to equip clinicians with autism‑specific skills. The curriculum combines sensory‑friendly communication techniques, evidence‑based clinical guidelines, and virtual‑reality simulations. In a pilot across 15 hospitals, provider confidence...
DNA-Protein Crosslinks Drive Inflammation Linked to Early Aging
Researchers have shown that unrepaired DNA‑protein crosslinks (DPCs) provoke chronic inflammation via the cGAS‑STING pathway, leading to premature aging and embryonic lethality in mice. The study identifies the SPRTN protease as the key enzyme that resolves DPCs during replication and...
Multiply Labs Partners with Nvidia to Bring Physical AI Robotics to Advanced Biomanufacturing
Multiply Labs announced a partnership with Nvidia to embed the company's Isaac Sim, GR00T, FoundationPose and FoundationStereo technologies into its robotic biomanufacturing platform. The collaboration enables digital twins, AI‑driven manipulation models and perception pipelines that accelerate automation of cell and...
Hippocampal Replay Persists but Loses Structure in Alzheimer’s Model
Researchers at UCL found that hippocampal replay persists but loses structural coherence in an Alzheimer’s mouse model. While the frequency of replay events remained normal, the ordered activation of place cells was disrupted, leading to weakened co‑firing patterns. This neural...
Immunotherapy Reduces Plaque in Mouse Arteries, Suggesting Coronary Disease Intervention
Researchers at Washington University and Amgen created a bispecific T‑cell engager (BiTE) that selectively eliminates fibroblast activation protein (FAP)‑positive modulated smooth‑muscle cells in mouse atherosclerosis models. The treatment cut plaque burden, lowered inflammation, and enhanced plaque stability, suggesting a new...
Differential Protein Network and Biological Functions Atlas From Multi-Tissue Proteomics in Patients with Depression
A multi‑tissue proteomic atlas was generated from patients with major depressive disorder, revealing distinct protein interaction networks and tissue‑specific functional signatures. The study integrated label‑free mass spectrometry across brain, blood, and peripheral tissues, identifying over 5,000 quantified proteins and dozens...
AI Use in Breast Cancer Screening Cuts Rate of Later Diagnosis by 12%, Study Finds
A Swedish trial of 100,000 women showed that AI‑supported mammography cut later‑stage breast cancer diagnoses by 12% and boosted early detection to 81% of cases. The AI system triaged low‑risk scans to a single radiologist and flagged high‑risk scans for...
Prenosis Raises $20M Series A Round
Prenosis, a biology‑based technology company, closed a $20 million Series A financing round. The round was led by PACE Healthcare Capital with co‑investors including UC Investments, Labcorp Venture Fund and state entities. Simultaneously, Prenosis secured a BARDA contract to commercialize Sepsis ImmunoScore®,...
Spinal Cord Stimulation Eases Parkinson’s Gait Issues
A recent clinical trial found that spinal cord stimulation (SCS) significantly improves gait disturbances in Parkinson's disease patients. The study, involving 45 participants, reported a 30% increase in walking speed and a marked reduction in freezing episodes. Researchers implanted epidural...
EDTA-GUI: Advanced Plant Lineage Classification Made Easy
EDTA‑GUI launches as a web‑based platform that streamlines plant lineage classification using the Enhanced DNA‑Taxonomy Algorithm (EDTA). The tool delivers 96% accuracy across more than 1,200 reference genomes while processing datasets ten times faster than traditional command‑line pipelines. It bundles...
The AI Hype Index: Grok Makes Porn, and Claude Code Nails Your Job
MIT Technology Review’s AI Hype Index highlights the polarizing capabilities of emerging models. It notes that Meta’s Grok can generate pornographic material, while Anthropic’s Claude Code can build websites and interpret medical scans. The piece warns of a seismic impact...
Real-Time Imaging Captures Contact Between Cells and Between a Single Neuron's Extensions
Japanese researchers at Osaka University introduced Gachapin, a rapid‑acting fluorescent marker that lights up when cells touch and extinguishes when they separate. The tool overcomes split‑GFP’s slow, irreversible signal, enabling real‑time visualization of transient cell‑cell contacts. A single‑component variant, Gachapin‑C,...
ROSS Announces CDA-200 Dual Shaft Mixer for Processing Viscous Pharmaceuticals
ROSS introduced the CDA‑200 Dual Shaft Mixer, engineered for high‑viscosity pharmaceutical batches up to 500,000 cP and 200 gallons per run. The system pairs a 10‑hp anchor agitator with a high‑speed disperser, creating a vortex that rapidly wets dry ingredients and ensures...
Refractive-Index Microscope Measures a Sample's Optical Properties with Pinpoint Accuracy
Researchers at TU Wien have created a hybrid microscopy technique that merges single‑molecule localization microscopy with atomic force microscopy to directly measure the refractive index of biological samples at nanometer scales. By using AFM‑derived topography to decouple distance‑related blur from...
Tele-Coaching Boosts Self-Efficacy in Gestational Diabetes
A recent BMC Nursing study compared nursing‑led tele‑coaching with traditional in‑person nursing for women with gestational diabetes. Participants receiving tele‑coaching reported higher self‑efficacy, better adherence to diet and exercise, and improved glucose control. The intervention leveraged regular video consults, personalized...
Ruxolitinib: Second-Line Treatment for Bronchiolitis Obliterans
Ruxolitinib, a JAK1/2 inhibitor, is being evaluated as a second‑line therapy for bronchiolitis obliterans (BO) in patients who fail conventional steroids. A recent multicenter Phase II trial involving 48 post‑transplant recipients reported a 45% median improvement in forced expiratory volume...
Takeda 'Anticipated' Medicare Negotiations for Top Seller Entyvio
Takeda’s incoming CEO Julie Kim said the company anticipated Medicare’s selection of Entyvio for upcoming coverage negotiations. Entyvio, Takeda’s top-selling inflammatory‑bowel‑disease biologic, generated roughly $2.5 billion in 2023 revenue. While the firm expects a constructive dialogue, it has not disclosed pricing...
Electrographic Cue Reactivity Aligns with Accumbens DBS
A recent study demonstrates that electrographic cue reactivity measured in the nucleus accumbens aligns closely with clinical outcomes of deep brain stimulation (DBS) for addiction and mood disorders. Researchers recorded local field potentials while subjects were exposed to drug‑related cues...
Scalable In-Situ Fabrication of Multimodal E-Skin
Researchers led by Lim, Choi, and Han have introduced a scalable in‑situ fabrication method for multimodal electronic skin that integrates pressure, temperature, and strain sensors directly onto robotic surfaces. The process combines deposition and patterning in a single workflow, using...
Takeda Is ‘Not in Favor’ of Trump’s MFN Deals, CEO-Designate Says
Takeda’s incoming chief executive publicly stated that the company is not supportive of President Donald Trump’s proposed “most favored nation” (MFN) agreements with pharmaceutical manufacturers. The MFN framework would grant U.S. drugmakers preferential pricing and market‑access terms, a move Takeda...
Strawberry Cultivars’ Anthocyanins and Anti-Inflammatory Effects
A recent study examined the anthocyanin profiles of multiple strawberry cultivars and linked higher pigment concentrations to measurable anti‑inflammatory effects in vitro and in animal models. Researchers identified three cultivars with up to 45 % more anthocyanins than standard varieties, correlating...
The Disrupted Fate of Pharmacy Startups
The House Judiciary Committee released a report alleging that CVS Health engaged in antitrust practices to suppress disruptive pharmacy startups. The findings highlight potential collusion with insurers and pharmacy benefit managers to limit market entry. Industry observers note that the...
Bead-Free CAR T Cells Via Two-Stage Microfluidics
Researchers introduced a two‑stage inertial microfluidic platform that enriches activated T‑cells without magnetic beads. The label‑free approach separates cells by size, shape and deformability, delivering higher purity and viability for CAR‑T manufacturing. Compatibility with closed‑system GMP processes lowers contamination risk...
Nanoclay-Melon Protein Coatings Extend Mushroom Shelf Life
Researchers have created an edible nanoclay‑melon protein coating that dramatically prolongs the shelf life of fresh mushrooms. Laboratory tests showed the coating extended freshness by up to seven days and cut weight loss by roughly 40% compared with untreated produce....
Pipeline Cuts for Sanofi; Breakthru Medicine Raises $60M
Sanofi announced a broad portfolio review that will cut several late‑stage drug programs, aiming to streamline its pipeline and improve cost efficiency. The cull affects multiple candidates across therapeutic areas, though specific names were not disclosed. In parallel, Breakthru Medicine...
